ELN and cancer: Many of the most promising candidates for cancer detection, non‐invasively, remain at the proteomic (e.g., collagen and elastin etc.)and metabolomic (e.g., tryptophan, phenylalanine, proline, ceramides and fatty acid metabolites) levels.